Treatment at the End of Life in Patients with Advanced Melanoma. A Multicenter DeCOG Study of 1067 Patients from the Prospective Skin Cancer Registry ADOReg
Frontiers in Immunology(2025)
Key words
immune checkpoint inhibitors,melanoma,ipilimumab,nivolumab,BRAF and MEK inhibitors,end of life
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined